NCT06286111

Brief Summary

In this study we investigate the correlation between RDW and POAF, as we use the RDW as a predictor for inflammation for prediction of POAF

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

April 25, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

August 6, 2024

Status Verified

February 1, 2024

Enrollment Period

1 month

First QC Date

February 23, 2024

Last Update Submit

August 3, 2024

Conditions

Heart; Surgery, Heart, Functional Disturbance as ResultAtrial FibrillationInflammatory Marker

Outcome Measures

Primary Outcomes (1)

  • Red cell distribution width as a predictor for Post-operative Atrial fibrillation after Open Heart Surgeries

    The correlation between Red cell distribution width and post operative atrial fibrillation after open heart sutgeries

    48 hours post operative

Eligibility Criteria

Age35 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient undergoing open heart surgery with cardiopulmonary bypass used intraoperative, with no history of cardiac tachyarrythemia and not using rythm control drugs with normal cardiac dimensions

You may qualify if:

  • Female or Male patient with range of age 35-65 years
  • Elective Cardiac surgery
  • Cardiopuomonary bypass machine used
  • Normal Sinus Rhythm

You may not qualify if:

  • Echo showing left atrial diameter above 4 cm
  • Patient on rythm control medications
  • Patient undergoing emergency surgery
  • History of cardiac Tachyarrhythemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain shams University

Cairo, Egypt

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2024

First Posted

February 29, 2024

Study Start

April 25, 2024

Primary Completion

June 1, 2024

Study Completion

August 1, 2024

Last Updated

August 6, 2024

Record last verified: 2024-02

Locations

EG(1)